To test the hypothesis that OCT-1 transcription factor may be an important therapeutic target in breast cancer, we analyzed migration, growth rate, and survivability of the MDA-MB231 cells with decreased OCT-1 expression levels. The gene discussed is POU2F1; the disease is breast carcinoma.